Physician profile
Michael E Ivan
NPI 1669700365
$224,691.77
in general payments reported to CMS, 2019-2025
14 companies · $60K in 2025
The $60K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,290 · 2020: $870 · 2021: $1,150 · 2022: $37K · 2023: $54K · 2024: $67K · 2025: $60K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $92K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $60K · Travel and Lodging: $21K · Food and Beverage: $6,983 · Gift: $99.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $92,241.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,425.00 |
| Travel and Lodging | $21,396.82 |
| Food and Beverage | $6,982.86 |
| Gift | $99.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $137,908.06 | 2021-2025 | Stealthstation S8 Platform, Visualase, Stealth Autoguide System |
| Omniscient Neurotechnology America Ltd | $71,748.09 | 2022-2025 | Quicktome |
| Astrazeneca Pharmaceuticals Lp | $5,737.48 | 2022-2023 | Andexxa |
| Medtronic USA, INC. | $4,633.42 | 2019-2020 | |
| Kls-Martin L.P. | $2,182.77 | 2023-2025 | |
| Stryker Corporation | $867.12 | 2019-2024 | N/A, Hydroset, Duramatrix |
| Monteris Medical Corporation | $571.69 | 2019-2025 | Neuroblate |
| Zimmer Biomet Holdings, INC. | $292.67 | 2021-2022 | |
| Penumbra, INC. | $243.96 | 2024-2025 | Red 72, Penumbra System |
| Nuvasive, INC. | $129.25 | 2021 | |
| Longeviti Neuro Solutions INC | $101.93 | 2025 | Clearfit |
| Lazarus 3d | $99.54 | 2024 | Pre-Sure |
| Brainlab, INC. | $96.94 | 2023 | Image Guided Surgical Device |
| Depuy Synthes Sales INC. | $78.85 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.